Jilin Province Huinan Changlong Bio-pharmacy Company Limited reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was CNY 216.12 million compared to CNY 172.34 million a year ago. Net income was CNY 27.4 million compared to CNY 47.99 million a year ago. Basic earnings per share from continuing operations was CNY 0.0489 compared to CNY 0.0857 a year ago.
For the nine months, sales was CNY 593.42 million compared to CNY 473.66 million a year ago. Net income was CNY 104.66 million compared to CNY 96.97 million a year ago. Basic earnings per share from continuing operations was CNY 0.1868 compared to CNY 0.173 a year ago.